Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
5.19
-0.96 (-15.61%)
At close: May 12, 2025, 4:00 PM
5.35
+0.16 (3.08%)
After-hours: May 12, 2025, 7:50 PM EDT
Company Description
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum.
The company also offers delivery models that include full service, functional service provider, and hybrid service structures.
In addition, it delivers phase I – IV clinical trial management, clinical pharmacology, and consulting services.
Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Fortrea Holdings Inc.
| Country | United States |
| Founded | 1996 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16,120 |
| CEO | Thomas Pike |
Contact Details
Address: 8 Moore Drive Durham, North Carolina 27709 United States | |
| Phone | 877 495 0816 |
| Website | fortrea.com |
Stock Details
| Ticker Symbol | FTRE |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001965040 |
| CUSIP Number | 34965K107 |
| ISIN Number | US34965K1079 |
| Employer ID | 92-2796441 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Thomas H. Pike | Chief Executive Officer and Chairman |
| Jill McConnell | Chief Financial Officer |
| Mark A. Morais | Chief Operating Officer and President of Clinical Services |
| Drayton Virkler | President and Chief Commercial Officer |
| Robert Parks | Chief Accounting Officer |
| Dr. John J. Doyle M.D. | Chief Scientific Officer and President of Consulting Services |
| Alejandro Martinez Galindo | Chief Information Officer |
| Dave Cooper | Chief Administrative Officer |
| Hima B. Inguva | Head of Investor Relations and Corporate Development |
| J. Stillman Hanson J.D. | General Counsel and Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 12, 2025 | 10-Q | Quarterly Report |
| May 12, 2025 | SCHEDULE 13D/A | Filing |
| May 12, 2025 | SCHEDULE 13G/A | Filing |
| May 12, 2025 | 8-K | Current Report |
| May 12, 2025 | 8-K | Current Report |
| May 6, 2025 | SCHEDULE 13G | Filing |
| May 2, 2025 | SCHEDULE 13G/A | Filing |
| May 2, 2025 | SCHEDULE 13G | Filing |
| Apr 28, 2025 | ARS | Filing |
| Apr 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |